ELOXX PHARMACEUTICALS, INC. Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net of $0 for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet · last filed 2017-11-14
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2017-06-30 was -$96.38K, a 472.69% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2016-12-31 was $96.38K, a 72.58% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2016 was $1.99M, a 60073.86% increase from fiscal 2015.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2015 was $3.31K.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ELOXX PHARMACEUTICALS, INC. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2013 was $371.59K, a 21.35% decline from fiscal 2012.
| Period end | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 3 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 6 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 9 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 12 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 12 month as first filed | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 180 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 183 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 186 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 189 month |
|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | -$96.38K derived: sum of 2 quarters · filed 2017-11-14 | -$96.38K derived: sum of 3 quarters · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2017-11-14 | |||||
| 2017-06-30 | -$96.38K derived: 10-Q 12 month − 10-Q 9 month · filed 2017-11-14 | -$96.38K derived: sum of 2 quarters · filed 2017-11-14 | $0.00 derived: sum of 3 quarters · filed 2017-11-14 | $208.71K 10-Q · filed 2017-11-14 | $249.03K 10-K · filed 2017-10-13 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-22 | $96.38K derived: sum of 2 quarters · filed 2017-05-22 | $305.09K 10-Q · filed 2017-05-22 | $330.95K derived: sum of 4 quarters · filed 2017-10-13 | |||||
| 2016-12-31 | $96.38K 10-Q · filed 2017-02-10 | $305.09K 10-Q · filed 2017-02-10 | $330.95K derived: sum of 3 quarters · filed 2017-10-13 | $998.59K derived: sum of 4 quarters · filed 2017-10-13 | |||||
| 2016-09-30 | $208.71K 10-Q · filed 2016-11-14 | $234.57K derived: sum of 2 quarters · filed 2017-10-13 | $902.21K derived: sum of 3 quarters · filed 2017-10-13 | $1.25M derived: sum of 4 quarters · filed 2017-10-13 | |||||
| 2016-06-30 | $25.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $693.50K derived: sum of 2 quarters · filed 2017-10-13 | $1.04M derived: sum of 3 quarters · filed 2017-10-13 | $1.99M 10-K · filed 2017-10-13 | |||||
| 2016-03-31 | $667.64K 10-Q · filed 2017-05-22 | $1.02M derived: sum of 2 quarters · filed 2017-05-22 | $1.97M 10-Q · filed 2017-05-22 | $1.97M derived: sum of 4 quarters · filed 2017-10-13 | |||||
| 2015-12-31 | $351.50K 10-Q · filed 2017-02-10 | $1.30M 10-Q · filed 2017-02-10 | $1.30M derived: sum of 3 quarters · filed 2017-10-13 | $1.30M derived: sum of 4 quarters · filed 2017-10-13 | |||||
| 2015-09-30 | $948.56K 10-Q · filed 2016-11-14 | $951.87K derived: sum of 2 quarters · filed 2017-10-13 | $951.87K derived: sum of 3 quarters · filed 2017-10-13 | $951.87K derived: sum of 4 quarters · filed 2017-10-13 | |||||
| 2015-06-30 | $3.31K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $3.31K derived: sum of 2 quarters · filed 2017-10-13 | $3.31K derived: sum of 3 quarters · filed 2017-10-13 | $3.31K 10-K · filed 2017-10-13 | |||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-05-12 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 4 quarters · filed 2016-10-13 | |||||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-16 | $0.00 10-Q · filed 2016-02-16 | $0.00 derived: sum of 3 quarters · filed 2016-10-13 | $0.00 derived: sum of 4 quarters · filed 2016-10-13 | |||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2016-10-13 | $0.00 derived: sum of 3 quarters · filed 2016-10-13 | $0.00 derived: sum of 4 quarters · filed 2016-10-13 | |||||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $0.00 derived: sum of 2 quarters · filed 2016-10-13 | $0.00 derived: sum of 3 quarters · filed 2016-10-13 | $0.00 10-K · filed 2016-10-13 | |||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2014-05-09 | $0.00 10-Q · filed 2014-05-09 | $99.76K derived: sum of 4 quarters · filed 2015-10-09 | $8.70M 10-Q · filed 2014-05-09 | ||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 10-Q · filed 2014-02-14 | $99.76K derived: sum of 3 quarters · filed 2015-10-09 | $327.30K derived: sum of 4 quarters · filed 2015-10-09 | $8.70M 10-Q · filed 2014-02-14 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $99.76K derived: sum of 2 quarters · filed 2015-10-09 | $327.30K derived: sum of 3 quarters · filed 2015-10-09 | $391.74K derived: sum of 4 quarters · filed 2015-10-09 | $8.70M 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $99.76K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | $327.30K derived: sum of 2 quarters · filed 2015-10-09 | $391.74K derived: sum of 3 quarters · filed 2015-10-09 | $371.59K 10-K · filed 2015-10-09 | $8.70M 10-K · filed 2013-09-11 | ||||
| 2013-03-31 | $227.54K 10-Q · filed 2014-05-09 | $291.98K derived: sum of 2 quarters · filed 2014-05-09 | $271.83K 10-Q · filed 2014-05-09 | ||||||
| 2012-12-31 | $64.44K 10-Q · filed 2014-02-14 | $44.29K 10-Q · filed 2014-02-14 | |||||||
| 2012-09-30 | -$20.15K 10-Q · filed 2013-11-14 | ||||||||
| 2012-06-30 | $472.46K 10-K · filed 2014-09-29 | ||||||||
| 2011-06-30 | $609.24K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |